Tempus Wealth Planning »

Sarepta Therapeutics shares owned by Tempus Wealth Planning

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Tempus Wealth Planning from 13F filings

Historical chart of Tempus Wealth Planning investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Tempus Wealth Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Tempus Wealth Planning

Quarter filed Position value Share count Share price at filing
2025-06-30 $353k 21k 17.10
2025-03-31 $229k 3.6k 63.82

More positions owned by Tempus Wealth Planning

Ge Aerospace Com New (GE)
Ge Vernova (GEV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Spdr Series Trust Portfoli S&p1500 (SPTM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Tesla Motors (TSLA)
Proshares Tr Pshs Ultra Qqq (QLD)
Proshares Tr Pshs Ult S&p 500 (SSO)

View all positions for Tempus Wealth Planning

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Renaissance Technologies
Two Sigma Investments
D. E. Shaw & Co
UBS Group
Standard Life Aberdeen
Two Sigma Advisers
First Trust Advisors
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Connor, Clark & Lunn Investment Management

View all funds holding Sarepta Therapeutics